The Helminthiasis (Parasitic Worm Infestation) drugs in development market research report provides comprehensive information on the therapeutics under development for Helminthiasis (Parasitic Worm Infestation), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Helminthiasis (Parasitic Worm Infestation). Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Helminthiasis (Parasitic Worm Infestation) and features dormant and discontinued products.
GlobalData tracks 37 drugs in development for Helminthiasis (Parasitic Worm Infestation) by 29 companies/universities/institutes. The top development phase for Helminthiasis (Parasitic Worm Infestation) is preclinical with 15 drugs in that stage. The Helminthiasis (Parasitic Worm Infestation) pipeline has 20 drugs in development by companies and 17 by universities/ institutes. Some of the companies in the Helminthiasis (Parasitic Worm Infestation) pipeline products market are: Pai Life Sciences, University of California San Diego and Drugs for Neglected Diseases initiative.
The key targets in the Helminthiasis (Parasitic Worm Infestation) pipeline products market include Signal Transducer And Activator Of Transcription 3, RNA Polymerase, and NACHT LRR And PYD Domains Containing Protein 3.
The key mechanisms of action in the Helminthiasis (Parasitic Worm Infestation) pipeline product include RNA Polymerase Inhibitor with one drug in Preclinical. The Helminthiasis (Parasitic Worm Infestation) pipeline products include four routes of administration with the top ROA being Oral and eight key molecule types in the Helminthiasis (Parasitic Worm Infestation) pipeline products market including Small Molecule, and Subunit Vaccine.
Helminthiasis (Parasitic Worm Infestation) overview
Helminthiasis, also known as worm infection, is any macroparasitic disease of humans or other animals in which a part of the body is infected with parasitic worms, known as helminths. There are numerous species that are not necessarily related, and are broadly classified into tapeworms, flukes, and roundworms. They often live in the gastrointestinal tract of their hosts, but they may also burrow into other organs, where they cause physiological damage.
For a complete picture of Helminthiasis (Parasitic Worm Infestation)’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
